166 related articles for article (PubMed ID: 18180801)
1. Novel function of complement C3d as an autologous helper T-cell target.
Knopf PM; Rivera DS; Hai SH; McMurry J; Martin W; De Groot AS
Immunol Cell Biol; 2008; 86(3):221-5. PubMed ID: 18180801
[TBL] [Abstract][Full Text] [Related]
2. C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells.
De Groot AS; Ross TM; Levitz L; Messitt TJ; Tassone R; Boyle CM; Vincelli AJ; Moise L; Martin W; Knopf PM
Immunol Cell Biol; 2015 Feb; 93(2):189-97. PubMed ID: 25385064
[TBL] [Abstract][Full Text] [Related]
3. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
4. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.
Toapanta FR; Ross TM
Immunol Res; 2006; 36(1-3):197-210. PubMed ID: 17337780
[TBL] [Abstract][Full Text] [Related]
5. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
[TBL] [Abstract][Full Text] [Related]
6. Targeting the Immune Complex-Bound Complement C3d Ligand as a Novel Therapy for Lupus.
Kulik L; Laskowski J; Renner B; Woolaver R; Zhang L; Lyubchenko T; You Z; Thurman JM; Holers VM
J Immunol; 2019 Dec; 203(12):3136-3147. PubMed ID: 31732528
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
Clemenza L; Isenman DE
J Immunol; 2000 Oct; 165(7):3839-48. PubMed ID: 11034390
[TBL] [Abstract][Full Text] [Related]
8. A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis.
Del Nagro CJ; Kolla RV; Rickert RC
J Immunol; 2005 Oct; 175(8):5379-89. PubMed ID: 16210644
[TBL] [Abstract][Full Text] [Related]
9. A minimum CR2 binding domain of C3d enhances immunity following vaccination.
Bower JF; Ross TM
Adv Exp Med Biol; 2006; 586():249-64. PubMed ID: 16893077
[TBL] [Abstract][Full Text] [Related]
10. Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.
Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
J Biol Chem; 2009 Apr; 284(14):9513-20. PubMed ID: 19164292
[TBL] [Abstract][Full Text] [Related]
11. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
12. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor.
Delcayre AX; Salas F; Mathur S; Kovats K; Lotz M; Lernhardt W
EMBO J; 1991 Apr; 10(4):919-26. PubMed ID: 1849076
[TBL] [Abstract][Full Text] [Related]
13. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).
Hannan JP
Curr Protein Pept Sci; 2016; 17(5):463-87. PubMed ID: 26916158
[TBL] [Abstract][Full Text] [Related]
14. Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide.
Mitsuyoshi JK; Hu Y; Test ST
Infect Immun; 2005 Nov; 73(11):7311-6. PubMed ID: 16239528
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
Hannan JP; Young KA; Guthridge JM; Asokan R; Szakonyi G; Chen XS; Holers VM
J Mol Biol; 2005 Feb; 346(3):845-58. PubMed ID: 15713467
[TBL] [Abstract][Full Text] [Related]
16. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
Thornton BP; Vetvicka V; Ross GD
Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
[TBL] [Abstract][Full Text] [Related]
17. CD21/CD35 in B cell activation.
Carroll MC
Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
[TBL] [Abstract][Full Text] [Related]
19. Regulation of humoral immunity by complement.
Carroll MC; Isenman DE
Immunity; 2012 Aug; 37(2):199-207. PubMed ID: 22921118
[TBL] [Abstract][Full Text] [Related]
20. Genetic CD21 deficiency is associated with hypogammaglobulinemia.
Thiel J; Kimmig L; Salzer U; Grudzien M; Lebrecht D; Hagena T; Draeger R; Voelxen N; Bergbreiter A; Jennings S; Gutenberger S; Aichem A; Illges H; Hannan JP; Kienzler AK; Rizzi M; Eibel H; Peter HH; Warnatz K; Grimbacher B; Rump JA; Schlesier M
J Allergy Clin Immunol; 2012 Mar; 129(3):801-810.e6. PubMed ID: 22035880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
